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Abstract 44 
Macroscale white matter pathways are the infrastructure for large-scale communication in the 45 
human brain and a prerequisite for healthy brain function. Disruptions in the brain’s connectivity 46 
architecture play an important role in many psychiatric and neurological brain disorders. Here we 47 
show that connections important for global communication and network integration are 48 
particularly vulnerable to brain alterations across multiple brain disorders. We report on a cross-49 
disorder connectome study comprising in total 1,033 patients and 1,154 matched controls across 50 
eight psychiatric and four neurological disorders. We extracted disorder connectome fingerprints 51 
for each of these twelve disorders and combined them into a ‘cross-disorder disconnectivity 52 
involvement map’ describing the level of cross-disorder involvement of each white matter 53 
pathway of the human brain network. Network analysis revealed connections central to global 54 
network communication and integration to display high disturbance across disorders, suggesting a 55 
general cross-disorder involvement and importance of these pathways in normal function.  56 
 57 
Main 58 
The macroscale connectome is the brain’s anatomical network for global communication and 59 
multimodal integration of information between brain areas 1. Topologically central connections have 60 
been argued to provide benefits for global neural integration 2 and healthy brain function 3. Due to 61 
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their high biological cost, these central connections may also be prone to a wide range of disease 62 
mechanisms 1. 63 
 64 
Disease-associated alterations in structural and functional brain connectivity play a role in a wide 65 
range of psychiatric and neurological conditions (see for a brief overview Supplementary Note). 66 
Potentially, these disconnectivity patterns converge across disorders to a substrate of connections 67 
that are generally vulnerable to disease effects. Such convergence is supported by observations that 68 
multiple neuropsychiatric disorders overlap in their involved functional neural circuits 4, their genetic 69 
risk factors 5 and their symptomatology 6. Meta-analyses of MRI studies have indicated high overlap 70 
in structural brain phenotypes and have suggested widespread anatomical and functional changes in 71 
densely connected ‘hub regions’ 7. So far, disease connectome investigations have been focused on 72 
the examination of brain disconnectivity in single or small sets of disorders, and lack power to 73 
identify cross-disorder biological patterns of white matter disconnectivity 8. A cross-disorder disease-74 
integrative approach provides opportunities to assess potential general vulnerability of connections 75 
in the human brain and gain insight into biological mechanisms shared across brain disorders 8. 76 
 77 
In this study, we performed a cross-disorder connectome analysis, integrating connectivity data 78 
across twelve brain disorders, comprising diffusion MRI data of in total 1,033 patients and 1,154 79 
matched controls, across eight psychiatric conditions (schizophrenia, bipolar disorder, attention 80 
deficit hyperactivity disorder, autism spectrum disorder, major depressive disorder, obesity, 81 
obsessive-compulsive disorder, posttraumatic stress disorder) and four neurological disorders 82 
(Alzheimer’s disease, its prodromal stage mild cognitive impairment, amyotrophic lateral sclerosis 83 
and primary lateral sclerosis). A ‘cross-disorder involvement map’ was constructed by combining 84 
derived ‘disconnectivity maps’ across the twelve conditions, identifying potential circuitry and 85 
network properties that play a general role in multiple disorders. We further combine cross-disorder 86 
involvement maps with results from network analysis of the human connectome, anatomical data 87 
and functional mappings of brain regions and functions. We show that connections important for 88 






Cross-disorder involvement map 93 
We examined diffusion MRI data of patients and controls across twelve brain disorders from 94 
previously published studies and cohorts (listed in Supplementary Method 1). Connectome maps 95 
were reconstructed by computing the level of connectivity between 219 distinct cortical brain 96 
regions (depicted by a subdivision of the Desikan-Killiany atlas, DK-219). Validation results using 97 
different parameter settings and different subparcellations of the Desikan-Killiany atlas (e.g. DK-114) 98 
are presented in the Supplementary Result 1. Patient-control matching was performed per dataset 99 
(to ensure group-wise matching of age and gender, see Supplementary Method 2) and after quality 100 
control of the data (see Supplementary Method 2) 1,033 patients and 1,154 matched controls were 101 
included for group analysis. An overview of the demographics is provided in Supplementary Figure 1 102 
and Table 1. Differences in connectivity strength (measured by fractional anisotropy) between 103 
patient and controls were computed for all connections in each disorder separately, and then 104 
combined into disorder disconnectivity maps (Figure 1A). In each disorder, a fixed number of 105 
connections (top 15%) with highest disconnectivity effects was selected as ‘disorder involved’, 106 
ensuring equal presence of all disorders in the final cross-disorder involvement map (validation of 107 
other settings (5% - 25%) and an alternative selection-free meta-analysis strategy, yielded similar 108 
effects, see Supplementary Result 2 and Supplementary Result 3). Disease maps were combined in a 109 
‘cross-disorder disconnectivity involvement map’ depicting across all twelve disorders, per 110 
connection, the percentage of disorders in which that connection was found to be affected (Figure 111 
1B). 112 
 113 
We next performed network-based statistics (NBS, see Methods for details, 9), a method that 114 
identifies subnetworks of edge-wise effects. We examined the subnetworks of connections with high 115 
cross-disorder involvement, comparing the observed subnetwork size with a null-distribution of 116 
random cross-disorder involvement observed when patients and controls are shuffled (10,000 117 
permutations). NBS analysis revealed four significant clusters of connections with high cross-118 
disorder involvement (among the set of connections involved in NBS threshold >30%, >40% and 119 
>45% of the disorders, all p < 0.05, Supplementary Figure 2), with the largest subnetwork containing 120 
80 regions and 216 connections, including superior frontal, central, posterior, and parietal regions (p 121 
< 0.001, Figure 1E). 122 
 123 
We continued by examining white-matter vulnerability from a neuroanatomical perspective, 124 
examining cross-disorder involvement of 38 major cortico-cortical white matter bundles parcellated 125 
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according to the ICBM-DTI-81 white matter atlas (see Methods). Significantly high levels of cross-126 
disorder involvement were observed in the body and splenium of the corpus callosum (body: p = 127 
0.008; splenium: p < 0.001), superior corona radiata (left: p = 0.008; right: p < 0.001) and posterior 128 
corona radiata (left: p = 0.008; right: p = 0.015, one-sided permutation testing, 10,000 permutations, 129 
Bonferroni corrected for multiple testing across 38 tracts). 130 
 131 
Region-wise cross-disorder involvement 132 
Averaging cross-disorder involvement across connections of each cortical area provided a measure 133 
of region-wise cross-disorder involvement (Figure 1D). We associated this region-wise cross-disorder 134 
involvement with cortical activation patterns associated with cognitive brain functions obtained 135 
from the NeuroSynth database. Region-wise cross-disorder involvement showed to be positively 136 
associated with brain functions related to movement, attention and cognitive control, including low-137 
level functions such as ‘eye movement’ (Pearson’s r(217) = 0.31, p < 0.001, 95% CI = 0.18-0.42) and 138 
‘motor’ (r(217) = 0.21, p = 0.025, 95% CI = 0.09-0.34), as well as high-level functions such as 139 
‘cognitive control’ (r(217) = 0.28, p < 0.001, 95% CI = 0.15-0.40), ‘cued attention’ (r(217) = 0.28, p < 140 
0.001, 95% CI = 0.16-0.40) and ‘visual attention’ (r(217) = 0.25, p = 0.004, 95% CI = 0.12-0.37) 141 
(Bonferroni corrected for multiple testing across 24 functions, see Supplementary Figure 3 and for a 142 
complete list of functions Supplementary Table 1). 143 
 144 
Edge-wise centrality measures 145 
We further investigated the vulnerability of connections and their contribution to local and global 146 
communication in the brain network. The topological role of connections was assessed using four 147 
edge-wise centrality measures computed on a reference connectome that was based on high-148 
resolution data from the Human Connectome Project (HCP) 10. We used HCP data to ensure that the 149 
computation of network measures was performed independently from any patient-control effects 150 
and any of the included disorder datasets. The contribution of a connection in global communication 151 
across the network was measured by means of ‘edge betweenness centrality’, which assesses the 152 
number of shortest topological paths through each connection. Connections with high betweenness 153 
centrality (top 25%, n = 290) were found to be significantly more involved across disorders as 154 
contrasted to subject-label permuted cross-disorder involvement maps (d = 0.41, one-sided 155 
permutation testing, 10,000 permutations, p < 0.001, Figure 2, see Methods). In contrast, no 156 
significant effect was observed in connections with a low betweenness centrality (lowest 25%, n = 157 
290, p = 1.000). We further examined an extended definition of global network integration by means 158 
of ‘network communicability’, a metric which takes into account all possible communication paths 159 
between nodes in the network 11. Brain connections that contribute the most to brain network 160 
6 
 
communicability (top 25%, n = 290) again showed significantly higher cross-disorder involvement (d 161 
= 0.18, p = 0.009), suggesting disproportional disease vulnerability in connections central to global 162 
brain communication. In contrast, connections with a strong contribution to local network 163 
organization (measured by network clustering, n = 290) did not show a predisposition for cross-164 
disorder involvement (p = 0.911). Finally, taking into account the projection distance of network 165 
connections (i.e. the physical length of connections in the human brain) also revealed higher cross-166 
disorder involvement among spatially long connections (top 25%, >50 mm, n = 290) in comparison 167 
with permuted disconnectivity effects (d = 0.62, p < 0.001, see Methods). 168 
 169 
Rich club organization 170 
We next investigated cross-disorder involvement in relation to hub and rich club organization of the 171 
human brain network 12. Densely connected hub regions in the human brain have been suggested to 172 
form a centrally connected ‘rich club’ with high levels of interconnectivity between hub regions, 173 
together forming system circuitry that may act as a central backbone for global communication and 174 
integration of information 13. Brain hubs were taken as the top 13% connected regions in the HCP 175 
reference connectome (Supplementary Figure 4), and network connections were categorized into 176 
rich club connections (7.6% of connections, n = 88) describing connections spanning between hub 177 
regions, feeder connections (27.7%, n = 321), describing connections spanning between hub and 178 
peripheral regions and local connections (64.7%, n = 751), describing connections spanning between 179 
peripheral regions. Significantly disproportionate cross-disorder involvement was observed among 180 
rich club connections as compared with local connections (d = 0.43, p < 0.001, one-sided 181 
permutation testing, 10,000 permutations, Figure 3) and as compared with feeder connections (d = 182 
0.28, p = 0.013). Feeder connections also showed higher cross-disorder involvement compared with 183 
local connections (d = 0.16, p = 0.009). 184 
 185 
Global white matter  186 
Widespread white matter differences in fractional anisotropy are often reported in psychiatric and 187 
neurological conditions (for a review, see 14) and could result in a general pattern of reduced 188 
connectivity across the connectome. To verify that a cross-disorder vulnerability of central 189 
connections is relatively independent from such global white matter changes, we compared the 190 
level of cross-disorder involvement of central connections with a null-distribution based on cross-191 
disorder involvement maps obtained by subject-label permutation, in which, per disease and per 192 
dataset, the global connectivity strength distribution across patient and control groups was 193 
preserved (see Methods). Using this alternative null-condition that controls for global changes in 194 
connectivity strength, connections with high betweenness centrality were again found to show 195 
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significantly higher cross-disorder involvement (n = 290, d = 0.36, p < 0.001, one-sided permutation 196 
testing, 10,000 permutations), indicative of these effects to go beyond disease related global 197 
fractional anisotropy changes. Furthermore, connections that contribute the most to brain network 198 
communicability also showed significantly higher cross-disorder involvement (n = 290, d = 0.16, p = 199 
0.012). In contrast, connections important for local network integration showed no predisposition 200 
for cross-disorder involvement (n = 290, p = 0.900). Cross-disorder involvement was also higher 201 
among the spatially longest connections (n = 290, d = 0.55, p < 0.001) and central rich club 202 
connections also showed significantly higher cross-disorder involvement (n = 88, d = 0.32, p = 0.003). 203 
 204 
Psychiatric and neurological disorders 205 
We further investigated connection vulnerability across the separate classes of psychiatric and 206 
neurological disorders (see also Supplementary Result 4). Connections central to global integration 207 
showed high vulnerability in psychiatric disorders (Supplementary Figure 5). Across neurological 208 
disorders, vulnerability of central connections was restricted to spatially long connections and rich 209 
club connections (results reported in Supplementary Result 4). Comparing the cross-disorder 210 
involvement of central connections of psychiatric and neurological disorders suggested that cross-211 
psychiatric disconnectivity patterns converge more strongly to central connections than 212 
disconnectivity patterns in neurological disorders (Supplementary Figure 6, see Supplementary 213 
Result 4). Stronger convergence in psychiatric disorders compared to neurological disorders was 214 
further suggested by results from NBS analysis that identified subnetworks with high cross-disorder 215 
involvement in psychiatric disorders but not in neurological disorders (Supplementary Result 4 and 216 
Supplementary Figure 5). 217 
 218 
Cross-disorder hyperconnectivity 219 
We further explored patterns of potential ‘disease-related increases in connectivity’ in patients 220 
compared to controls, as a reflection of cross-disorder hyperconnectivity. Using the same procedure 221 
as for the cross-disorder disconnectivity involvement map, we constructed a cross-disorder 222 
hyperconnectivity map describing for each connection the percentage of disorders in which a 223 
connection was found to show increased connectivity (i.e. higher FA in patients as controls). NBS 224 
analysis revealed two subnetworks with high cross-disorder involvement (at NBS thresholds > 30% 225 
and > 40%, one-sided permutation testing, 10,000 permutations), with the largest significant 226 
subnetwork including 58 regions and 132 connections. This network was left lateralized and included 227 
connections of the anterior cingulate gyrus, orbital, medial, inferior and medial frontal regions and 228 
superior temporal regions (p = 0.026, Figure 4). Subsequent neuroanatomical mapping of cross-229 
disorder hyperconnectivity did not reveal a significant concentration of cross-disorder involvement 230 
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to any of the white matter bundles (all p > 0.05, one-sided permutation testing, 10,000 231 
permutations, Bonferroni corrected for multiple testing across 38 tracts). Furthermore, functional 232 
mapping showed no significant positive correlations between region-wise cross-disorder 233 
involvement and functional mappings (all p > 0.05, Pearson’s correlation, Bonferroni corrected for 234 
multiple testing across 24 functions).  235 
 236 
We next tested whether peripheral connections possibly showed higher cross-disorder involvement 237 
in hyperconnectivity. We found significantly higher cross-disorder hyperconnectivity compared with 238 
subject-label permuted cross-disorder hyperconnectivity maps in connections with low betweenness 239 
centrality (lowest 25%, n = 290, d = 0.20, p = 0.002) and connections with a relatively low 240 
contribution to communicability (n = 290, d = 0.33, p < 0.001). Connections with low clustering did 241 
not show a particularly higher cross-disorder hyperconnectivity (p = 0.132). Furthermore, higher 242 
cross-disorder hyperconnectivity was found to be also particularly concentrated along short-range 243 
connections (<8.3 mm, n = 290, d = 0.27, p < 0.001). Local connections (n = 751) that displayed a 244 
peripheral role in the rich club organization, showed higher cross-disorder hyperconnectivity than 245 
more central feeder connections (n = 321, d = 0.19, p = 0.003) or rich club connections (n = 88, d = 246 
0.29, p = 0.004). 247 
 248 
Individual disorder maps 249 
To verify that the observed results were not driven by the disconnectivity profile of any included 250 
disorder, we performed a leave-one-disorder-out analysis in which we repeated our analyses leaving 251 
out one disorder at a time (see Supplementary Result 5). This analysis confirmed high vulnerability of 252 
connections important for global integration and higher cross-disorder involvement of rich club 253 
connections compared with feeder and local connections (see Supplementary Result 5) and ruled 254 
out that the effects were mainly driven by one specific disorder. This generality was further 255 
underscored by the observation that at most three of the twelve disorder disconnectivity maps did 256 
not contribute to the vulnerability of central connections (Supplementary Figure 7). 257 
 258 
The leave-one-disorder-out analysis further provided an opportunity to quantify the overlap of 259 
disorder disconnectivity maps and the cross-disorder involvement map. We tested the distribution 260 
of disconnectivity for each disorder between disorder-specific connections (affected in zero, one or 261 
two disorders of the 11 other disorders, i.e. excluding the examined disorder) and connections 262 
commonly affected (in four or more disorders) (Figure 5). Schizophrenia (d = 0.77, p < 0.001, two-263 
sided permutation testing, 10,000 permutations, Bonferroni corrected for multiple testing across 12 264 
disorders), PLS (d = 0.71, p < 0.001), ALS (d = 0.71, p < 0.001), bipolar disorder (d = 0.42, p = 0.001), 265 
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obesity (d = 0.33, p = 0.019), Alzheimer’s disease (d = 0.31, p = 0.040) and ASD (d = 0.31, p = 0.035) 266 
showed significantly higher disconnectivity in commonly affected connections. MCI (p = 0.073), 267 
ADHD (p = 0.193), PTSD (p = 1), MDD (p = 0.767) and OCD (p = 0.152) did not show significant 268 
differences. The increased disconnectivity of commonly vulnerable connections in seven out of 269 
twelve disorders provides further evidence that the cross-disorder involvement map incorporates 270 
disconnectivity patterns that are relatively general across the majority of brain disorders. 271 
 272 
Variation analyses 273 
To ensure our results were generalizable and independent of specific parameter settings, 274 
reconstruction method or applied analysis, we repeated our analyses with various alternative 275 
research design choices. We repeated our analyses using different analysis parameters for the 276 
percentage of disorder-involved connections (Supplementary Result 2, Supplementary Figure 8), 277 
percentage of central connections (Supplementary Result 6, Supplementary Figure 9) and 278 
percentage of hub regions (Supplementary Result 7, Supplementary Figure 10). Different analysis 279 
strategies were tested including a second meta-analysis method that averaged weighted 280 
disconnectivity effects across disorders (Supplementary Result 3, Supplementary Figure 11). The 281 
group connectome map was based on group-thresholding that reduced the number of included false 282 
positive connections, but could overrepresent short-range connections in the group connectome 283 
map 15. Therefore, we also repeated our analyses using an alternative grouping method that 284 
preserved connection-length and ensured a balanced sampling of short- and long-range connections 285 
in the group connectome map 16 (see Supplementary Result 8). To further ensure our findings were 286 
not influenced by connection prevalence (i.e. the number of times a connection could be 287 
reconstructed in the population reflecting study power), we verified our results examining the 288 
subset of most highly consistent connections (see Supplementary Result 9). 289 
 290 
Discussion 291 
Our findings suggest that connections central to network integration and communication in the 292 
human brain are potential hotspots for white matter disconnectivity across multiple brain disorders. 293 
Cross-disorder disconnectivity was examined in 1,033 patients and 1,154 matched controls across a 294 
range of eight psychiatric and four neurological disorders and suggest the common involvement of 295 
central connections in multiple brain disorders. We note that our findings do not suggest that all 296 
disorders involve change to central connections of the brain network, but that central connections 297 
are potential common players across multiple disorders, with a potential high vulnerability of these 298 
connections to a wide range of disease processes. Our cross-disorder findings provide three lines of 299 
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evidence to support such a cross-disorder vulnerability of central connections of the human brain 300 
network. 301 
 302 
First, edge-wise network measures revealed connections critical for network efficiency and 303 
communicability to display high cross-disorder involvement (Figure 2). This result extends earlier 304 
reports of affected efficiency of structural networks in for example depression17 and in Alzheimer’s 305 
disease, schizophrenia, multiple sclerosis and ALS (see 18 for a review), suggesting that these effects 306 
are perhaps not all disease-specific, but potentially more general to brain disorders than previously 307 
reported. Furthermore, our results stress the hypothesized importance of efficient integration of 308 
information for healthy brain function 19, with disruptions in central connections potentially leading 309 
to disproportional effects in brain dysfunction 20. 310 
 311 
A second line of evidence for the vulnerability of central connections is the observation of high 312 
cross-disorder involvement among connections characterized by long physical distances (Figure 2). A 313 
longer projection distance does not necessarily imply topological importance, but following a 314 
hypothesized trade-off in brain organization between minimizing wiring-cost and topological 315 
integration, connections spanning long physical distances are expected to be extraordinarily 316 
beneficial to network topology 1. This elevated vulnerability of physically long connections is in line 317 
with studies reporting affected fiber tracts such as the superior and inferior longitudinal fasciculus 318 
in, for example, ADHD 21, ASD 22, OCD 23, and schizophrenia 24. Post-hoc analysis showed that high 319 
cross-disorder involvement of spatially long connections is at least partly driven by a centralization 320 
of effects among interhemispheric connections (see Supplementary Result 10). 321 
 322 
Third, rich club connections are found to display significantly higher cross-disorder involvement as 323 
compared to connections of peripheral regions (Figure 3). This observation is in line with studies 324 
showing the involvement of the rich club in several disorders, such as schizophrenia 25, autism 325 
spectrum disorder 26, Huntington's disease 27, and Alzheimer’s disease 17 and studies reporting on 326 
widespread overlap in gray matter and resting-state functional abnormalities across disorders in 327 
central hub regions 7. We conclude from this that connections central to global integration of 328 
information display an elevated vulnerability across a wide range of mental disorders. 329 
 330 
The observed cross-disorder involvement of central connections is argued to result from an 331 
accumulation of different disease mechanisms across disorders 28. A potential heterogeneous 332 
etiology of the vulnerability of central connections is in line with the interpretation that our results 333 
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reflect small to medium effect sizes 29 and is supported by the observation that central connections 334 
are involved in both psychiatric and neurological disorders, but with different impact 335 
(Supplementary Figure 6). Several biological mechanisms and disease pathways have been proposed 336 
to contribute to this general vulnerability of central connections. Central regions and connections 337 
have been argued to be biologically expensive, characterized by complex cytoarchitecture 30, high 338 
metabolism 19 and high neuronal activity 31. This high biological cost has been argued to cause a 339 
general vulnerability to a wide range of disease processes, such as reductions in the supply of 340 
oxygen or other metabolic resources 32. Central connections may also display a high cross-disorder 341 
involvement as the result of their topological centrality and associated risk to propagating disease 342 
processes 28. Furthermore, long-range central connections may be particularly vulnerable to focal 343 
white matter degeneration, with the chance of a connection being affected by random white matter 344 
lesions being proportional to its physical length, resulting in a higher predisposition of long-range 345 
central connections to general white matter atrophy compared with short range connections. 346 
Central connections of the brain have been noted to display a prolonged development 33, which may 347 
further increase their general vulnerability with these connections at elevated risk to late 348 
neurodevelopmental stress, substance use and/or dysregulation of for example hypothalamic-349 
pituitary-adrenal axis function 34. Alternatively, a high vulnerability of central connections might also 350 
relate to overlap in symptomatology across disorders. We observed that connections with high 351 
cross-disorder involvement connect regions involved in attention and cognitive control, which are 352 
cognitive brain functions commonly affected in a wide range of brain disorders 35. 353 
 354 
This cross-disorder connectome study complements previous meta-analyses that localized cross-355 
disorder vulnerability in other brain modalities such as functional hypo- and hyperactivation and 356 
gray matter abnormalities 36. In line with our observed vulnerability of central connections, cross-357 
disorder abnormalities in resting-state functional connectivity have been reported in brain regions 358 
important for neural integration 37. Meta-analyses have further associated hyperconnectivity 359 
between the default mode network and executive networks with transdiagnostic factors 38, results 360 
that overlap with the here observed cross-disorder vulnerability of white matter tracts involved in 361 
cognitive control. 362 
 363 
 Integrating cross-disorder findings from multiple modalities provides the opportunity to gain further 364 
insight in the biological mechanisms that overlap and dissociate across disorders 39. An exploratory 365 
comparison of the overlap and dissociation between previously reported 7 gray matter effects and 366 
white matter disease involvement revealed the left caudal middle frontal, left superior frontal and 367 
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left cuneus to show high cross-disorder involvement in both white-matter disconnectivity as well as 368 
gray matter abnormalities (Figure 6, see Supplementary Result 11). In contrast, regions like the left 369 
superior frontal, right paracentral, right superior frontal and right medial orbitofrontal cortex tend to 370 
show high white matter cross-disorder disconnectivity, but low general vulnerability to gray matter 371 
abnormalities, while the left fusiform area and left caudal anterior cingulate cortex tend to show 372 
high gray matter vulnerability but low cross-disorder disconnectivity involvement. The differential 373 
involvement of brain regions in both types of cross-disorder involvement suggests a complex 374 
interaction between gray and white matter cross-disorder disease pathways. Further investigation of 375 
cross-disorder mechanisms that are associated with either gray or white matter abnormalities 376 
provides a promising avenue to identify explicit cross-disorder disease pathways that are linked with 377 
specific brain phenotype outcomes. 378 
 379 
Genetics and heritability studies offer the potential to gain further understanding of the pathology 380 
underlying cross-disorder disconnectivity. Shared genetic etiology is observed across many 381 
psychiatric and neurological disorders 40, with shared genetic risk factors providing converging 382 
evidence for common underlying biological processes across brain disorders 41. Examination of 383 
structural disconnectivity and genetic information in a multi-modal and cross-disorder approach may 384 
further identify cross-disorder and disorder-specific biological pathways 42. 385 
 386 
The observation of overlapping disconnectivity patterns across brain disorders is in agreement with 387 
the hypothesis that brain disorders are interrelated 41 and prompts a careful consideration of disease 388 
disconnectivity findings. Disconnectivity findings of single-disorder connectome examinations are 389 
often interpreted as disorder-specific disconnectivity effects. Such misattribution is perhaps most 390 
problematic in the development of biomarkers for brain disorders based on disconnectivity 391 
fingerprints, where it could result in overestimation of the disorder specificity of a presented 392 
biomarker. Our findings argue for a cross-disorder approach to connectome disease studies, and 393 
specifically the development of biomarkers that can disentangle disorder-shared and disorder-394 
specific disconnectivity effects. 395 
 396 
Several methodological issues have to be considered when interpreting our findings. While 397 
combining data from multiple studies may implicitly account for real-world heterogeneity and 398 
improve generalizability of observed results 43, it overlooks disorder-age interactions and it reduces 399 
statistical power as a result of inter-study heterogeneity in diagnoses, demographics, scanner and 400 
MRI acquisition protocols. We are aware of this limitation and aimed to match for age effects and 401 
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maximize statistical power by directly comparing patients and matched controls within each study 402 
first, before combining information across the twelve disorders. Second, disorder disconnectivity 403 
fingerprints were based on structural brain networks obtained by diffusion-based MRI, with white 404 
matter microstructural integrity assessed by means of the metric of fractional anisotropy 44. 405 
Fractional anisotropy is however only an indirect marker of the micro-scale architecture of white 406 
matter tissue. Diffusion weighted imaging has recognized limitations with respect to the 407 
reconstruction of complex fibers and connectome mapping 45, which might result in underestimation 408 
of disconnectivity effects within and across disorders. Third, our conclusions are based on effects 409 
observed across twelve disorders, and it remains unclear whether our conclusions could be 410 
generalized to an even wider range of brain disorders. To verify that the results were not driven by a 411 
single disorder, we performed a leave-one-disorder-out validation analysis in which all analyses were 412 
repeated leaving out one disorder at a time. Moreover, we repeated all analyses using a strict set of 413 
brain disorders, excluding MCI and obesity, which showed similar results (see Supplementary Result 414 
12). We also examined neurological and psychiatric disorders separately, confirming vulnerability of 415 
central connections in both classes of disorders. Investigating potential further clustering of 416 
disorders within these two large classes of disorders based on disorder disconnectivity patterns may 417 
provide further insights in more detailed biological relationships between and across disorders. 418 
 419 
Our cross-disorder comparative findings suggest shared connectome pathology across brain 420 
disorders, with central connections important for global communication and neural integration 421 
forming potential ‘hot spots of disconnectivity’ in the human brain. Our cross-disorder comparison 422 
showed varying involvement of central connections across disorders, suggesting that each disorder 423 
may include a balance between disorder-specific and disorder-shared disconnectivity. Future 424 
examinations untangling disconnectivity effects will provide better understanding of which brain 425 
alterations are general and which effects are unique for brain disorders, providing opportunities to 426 
develop MRI based biomarkers for mental disorders. 427 
 428 
Methods 429 
Studies and subjects 430 
Diffusion MRI data of 2,681 patients and controls of twelve disorders were included. All participants 431 
or legal tutors (in case of children under the age of 18) provided written informed consent and all 432 
studies were approved by their local ethics committee for research in humans (see Supplementary 433 
Method 1). Data included diffusion-weighted imaging (DWI) data of previously reported studies on 434 
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schizophrenia (three datasets available, set I, II and III) (COBRE, 46 and 47), bipolar disorder 48, 435 
attention deficit hyperactivity disorder (ADHD) 49, autism spectrum disorder (ASD, four datasets) 436 
(ABIDEII and the study of van Belle et al. 49), major depressive disorder (MDD) 50, obesity 51, 437 
obsessive-compulsive disorder (OCD) 52, posttraumatic stress disorder (PTSD, two datasets, set I and 438 
set II) (ADNI-DOD adni.loni.usc.edu and 53), and four neurological disorders, Alzheimer’s disease (AD, 439 
two datasets, set I and set II) (ADNI and 54), mild cognitive impairment (MCI, two datasets, set I and 440 
set II) (ADNI and 54), amyotrophic lateral sclerosis (ALS) 55 and primary lateral sclerosis (PLS) 55). 441 
Supplementary Figure 1 provides an overview of all data included and a summary is provided in 442 
Table 1. Further details including MRI acquisition protocols and demographics are outlined in 443 
Supplementary Method 1 and Supplementary Table 2. Within each dataset, patients and controls 444 
were matched on age, sex, scanner settings and where possible other demographics (procedure 445 
described in the Supplementary Method 2). 446 
 447 
Data processing 448 
DWI Tractography. Data preprocessing of DWI and T1-weighted images of individuals included the 449 
following steps: the anatomical T1-weighted image was parcellated into 219 distinct cortical regions 450 
(111 left-hemispheric and 108 right-hemispheric regions) according to a subdivision of FreeSurfer’s 451 
Desikan-Killiany atlas 56 using FreeSurfer 57. This subdivision provided high methodological 452 
robustness while remaining sensitive to changes in connectivity 56. Underscoring the influence of 453 
parcellation and network size on network measures 58, we repeated analyses using a different 454 
subparcellation of the Desikan-Killiany atlas (DK-114, 114 regions, data presented in the variation 455 
analyses section and Supplementary Result 1). Second, the individual parcellation map was co-456 
registered to the DWI data using an affine transformation mapping of the T1-weighted image to the 457 
DWI image. Third, diffusion-weighted images were corrected for eddy current distortions and head 458 
motion using the FMRIB Software Library 59. If reversed phase encoding data was available (datasets 459 
listed in SI Table 2), susceptibility induced distortions were estimated and incorporated in the 460 
preprocessing 60. Fourth, a tensor was fitted to the diffusion signals in each voxel using a robust 461 
tensor fitting algorithm 61 and subsequently fractional anisotropy (FA) was derived 62. Given the 462 
mostly clinical diffusion MRI protocols used for data acquisition, simple deterministic tensor 463 
reconstruction (DTI) (as compared to more advanced diffusion profile reconstruction methods) was 464 
used to minimize the potential influence of false positives on network reconstruction and 465 
subsequent computation of network metrics 15. This relatively simple reconstruction of the diffusion 466 
signal is a limitation of our cross-disorder examination, potentially leading to incomplete 467 
reconstruction of complex fiber pathways and an underestimation of cross-disorder disease effects 468 
63. Fifth, white matter pathways were reconstructed using fiber assignment by continuous tracking 469 
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(FACT) 64, with streamline reconstruction starting from eight seeds in every cerebral white matter 470 
voxel. Fiber tracking was continued until a streamline showed high curvature (> 45º), exited the 471 
brain mask, or when a streamline entered a voxel with low fractional anisotropy (< 0.1). The mean 472 
FA value of a streamline was computed as the weighted average FA value over all voxels that a 473 
streamline passed. 474 
 475 
Network reconstruction. For each individual dataset, reconstructed streamlines and cortical 476 
parcellation were combined into a weighted network. The 219 cortical areas were chosen as nodes 477 
in the network and two regions were considered connected if at least one reconstructed streamline 478 
was found to touch both cortical regions. The weight of connections was taken as the mean 479 
fractional anisotropy (FA) of streamlines involved 44. An overview of FA distribution per dataset and 480 
patient and control group is provided in Supplementary Figure 12 and Supplementary Table 3. 481 
 482 
Cross-disorder analysis 483 
Cross-disorder examination of disorder-related disconnectivity was performed in two steps. Patient 484 
and control data were first compared within each dataset (in contrast to the alternative of pooling 485 
all data into one large dataset) to ensure that patients and controls were matched on age, sex and 486 
other demographics and scanner settings. This comparison provided for each disorder a 487 
disconnectivity map quantifying the differences in connectivity strength between patients and 488 
matched controls. Second, patient-control matched disorder disconnectivity maps were combined 489 
across the twelve disorders to determine the distribution of disconnectivity effects across network 490 
connections of the brain. This two-step approach optimized comparability of data across studies 491 
with different MRI acquisition protocols. In what follows, we describe this procedure in more detail, 492 
including the construction of the disorder disconnectivity maps and the cross-disorder involvement 493 
map, followed by the performed statistical analyses. 494 
 495 
Step 1: Disorder disconnectivity map 496 
Per disorder, a disconnectivity map was constructed by assessing the between-group difference in 497 
FA of connections between patients and controls quantified by a Student’s t-test statistic. As such, 498 
we tested for lowered FA connectivity strength in the patient group compared to the controls. To 499 
incorporate possible differences in degrees of freedom across connections, t-test statistics were 500 
transformed to z-scores derived from the p-values using the equivalent area under the curve. 501 
For the disorders ASD, PTSD, schizophrenia, Alzheimer’s disease and MCI, for which multiple 502 
datasets were available, a disorder disconnectivity map was calculated per dataset and then 503 
combined into an average disorder disconnectivity map using Stouffer’s method for combining 504 
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independent tests by averaging the z-scores in the disorder disconnectivity maps across datasets 505 
weighted proportional to the effective sample size of the dataset 65. 506 
In total, this resulted in a disorder disconnectivity map for each of the 12 included brain disorders. 507 
Next, the top 15% connections with highest z-scores were selected as the set of most involved 508 
connections in that disorder, performing, per disorder, a proportional thresholding on the disorder-509 
specific disconnectivity map with a density of 15% 66. Results using 5%, 10%, 20% or 25% involved 510 
connections are presented in the Supplementary Result 2. Results using a second selection-free 511 
meta-analysis method in which connection involvement was weighted by the full z-scores in the 512 
disorder disconnectivity maps are also presented in the Supplementary Result 3. 513 
 514 
Step 2: Cross-disorder involvement map 515 
The twelve thresholded and patient-control matched disorder disconnectivity maps were combined 516 
into a total cross-disorder involvement map. To maximize comparability across studies and to avoid 517 
any potential bias to one of the included datasets, connection effects were included for those 518 
connections present in a reference connectome map based on high-quality data of the Human 519 
Connectome Project (HCP, 500 Subjects Release of the Human Connectome Project) 67 (see 520 
Supplementary Method 3 for details on the HCP group connectome reconstruction). A cross-disorder 521 
involvement map was formed by adding up all thresholded disorder disconnectivity maps and 522 
dividing it by the number of disorders in which each connection was present, thus computing per 523 
connection the percentage of disorders in which this connection was involved. 524 
 525 
White matter bundles 526 
The Johns Hopkins University ICBM-DTI-81 white-matter atlas as included in FSL was used as a 527 
segmentation of 48 white matter bundles in standard MNI space 68. The extent to which each 528 
reconstructed connection overlapped with a bundle was computed as a percentage of overlap based 529 
on high-resolution tractography of subjects in the reference connectome dataset. The volume (i.e. 530 
number of voxels) shared between a connection and bundle was computed, divided by the total 531 
volume of the bundle in each subject and averaged across subjects, providing the percentage of 532 
overlap between a connection and bundle. Cross-disorder involvement of white-matter bundles was 533 
then calculated as the sum of cross-disorder involvement over all connections weighted by this 534 
percentage of overlap. Ten bundles showed no overlap with any of the reconstructed connections 535 
and were excluded from the analysis (See Supplementary Table 4 for an overview of the 38 included 536 
white matter bundles). This procedure was repeated for the 10,000 randomized cross-disorder 537 
involvement maps, providing for each white matter bundle a null-model of cross-disorder 538 
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involvement under subject-label permutation. Significance was assessed using permutation testing 539 
(Bonferroni correction was applied to correct for multiple testing across 38 white matter bundles).  540 
 541 
Region-wise cross-disorder involvement 542 
Region-wise cross-disorder involvement was derived by averaging cross-disorder involvement of 543 
connections adjacent to each region. Functional correlates of high regional cross-disorder 544 
involvement were examined using brain function maps obtained from the NeuroSynth database 545 
(www.neurosynth.org) 69. The NeuroSynth database provides statistical mapping in standard MNI 546 
space of neural and cognitive states, named “terms”, based on a meta-analysis of literature. For 547 
every term, we downloaded the association-test map that displays the preferential association of 548 
voxels with the term. A regional term involvement map was formed by combining the association-549 
test statistics across all voxels of each brain region using sample size based meta-analysis 70. We 550 
examined 24 groupings of 99 terms that described distinct interpretable brain functions 71. The 551 
associated regional brain function involvement maps were computed as the number of terms per 552 
brain function that exceeded a z-score threshold of 2.6 in a region. Next, the region-wise cross-553 
disorder involvement map was correlated with all regional topic maps to identify which topics had 554 
similar regional distributions as the cross-disorder involvement map (normality of the data 555 
distributions was not formally tested and Bonferroni correction was applied to correct for multiple 556 
testing across 24 functions). 557 
 558 
Network analysis 559 
The centrality of connections in the network structure was considered with respect to rich club 560 
organization, edge-wise global and local network measures and physical wiring length. Metrics were 561 
computed on the reference connectome to ensure independence of the examined datasets.  562 
Global network organization. Global network integration was examined from the perspective 563 
of the ease of communication between nodes in the network. Centrality of connections with respect 564 
to the shortest topological paths in the network was measured by counting the number of shortest 565 
topological paths through each network connection using the metric of edge betweenness 72. 566 
Network integration was considered by examining the metric of network communicability, 567 
measuring all possible walks between nodes 11. The contribution of connections to communicability 568 
was assessed by edge-removal statistics 73. Removal-effect of each connection on network 569 
communicability was quantified as the difference (in terms of percentage) between the network 570 
communicability before and after removal of a connection. 571 
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Local network organization. The role of network connections in local network organization was 572 
assessed through the contribution of each connection to network clustering 72. The removal-effect of 573 
each connection on global network clustering was quantified as the difference (i.e., percentage of 574 
change) in global clustering before and after removal of the connection.  575 
Spatial embedding. Projection length of each connection was calculated as the average physical 576 
length of a connection in the HCP reference dataset. 577 
Rich club organization. Central connections were identified with respect to the rich club 578 
organization of the reference network, describing the total collective of high-degree hub regions and 579 
their connections 12. Regional degree was computed on the basis of the reference connectome to 580 
avoid any potential data-driven bias in any class of connections towards the included datasets. Hub 581 
regions were selected as regions with a degree above 14 (top 13% regions with the highest regional 582 
degree, 29 regions, Supplementary Figure 4, listed in Supplementary Table 5) in line with previous 583 
hub definitions 2. Network connections were subsequently categorized into rich club connections, 584 
describing connections spanning between hub regions, feeder connections, describing connections 585 
spanning between hub and peripheral regions, or local connections, describing connections between 586 
peripheral regions 2. Analyses were repeated with connections classes derived from a smaller and 587 
larger set of hub regions, revealing consistent results (see Supplementary Result 6). 588 
 589 
Statistical analysis 590 
Cross-disorder involvement. Significant subnetworks in the brain with increased cross-disorder 591 
involvement levels were identified using Network Based Statistics 9. The cross-disorder involvement 592 
map was binarized by including connections with cross-disorder involvement percentages above a 593 
specified NBS-threshold. Multiple NBS-thresholds (0%, 5%, …, 100%) were considered, capturing the 594 
trade-off between specificity and sensitivity of the NBS-analysis. The number of connections in the 595 
greatest component of the thresholded network was counted. Significance of this cluster was 596 
assessed using permutation testing by comparison with the distribution of greatest component sizes 597 
in a null condition in which disease effects were randomized. For this, for each permutation, a cross-598 
disorder involvement map was calculated on a permuted subject sample in which subject labels (i.e. 599 
controls and patients) were randomly reassigned (keeping patient and control group sizes intact). 600 
10,000 permutations were examined and the percentage of the permutations in which the greatest 601 
component was larger or equal to the observed greatest component was assigned as p-value to the 602 
observed cross-disorder involvement. We used an alpha level of 0.05 for this and all other tests. 603 
Edge-wise centrality measures. The 25% most central connections selected by global network 604 
integration, local network integration and the spatial embedding were examined. In the variation 605 
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analyses, also other reasonable percentages (5%, 10%, …, 45%) for selecting central connections 606 
were examined and verified to show similar results. Cross-disorder involvement levels were 607 
compared with the levels expected when disconnectivity was randomly distributed using 608 
permutation testing, this to verify independence of our results from connection properties such as 609 
connection prevalence or group-average connection strength. For each permutation, subject labels 610 
were randomly reassigned and cross-disorder involvement maps were calculated using the 611 
permuted subject-labeling. 10,000 permutations were computed and cross-disorder involvement 612 
levels of the subsets of central connections were calculated for each permutation. Based on this null 613 
distribution, the original effect was assigned a p-value as the percentage of permutations in which 614 
the cross-disorder involvement was equal to or exceeded the observed cross-disorder involvement. 615 
Standardized effect sizes were measured by Cohen’s d approximated as difference between the 616 
observed average cross-disorder involvement of central connections and the average cross-disorder 617 
involvement of central connections in subject-label permuted cross-disorder involvement maps 618 
divided by the standard deviation of the observed cross-disorder involvement of central 619 
connections. 620 
Rich club organization. Differences in mean cross-disorder involvement between rich club and 621 
feeder, rich club and local, and feeder and local connection classes were statistically assessed using 622 
permutation testing (10,000 permutations). In each permutation, connection class labels were 623 
randomly shuffled and mean cross-disorder involvement of the classes was computed over the 624 
permuted connections. Differences in cross-disorder involvement between connection classes were 625 
computed for all permutations. The observed difference in cross-disorder involvement between two 626 
connection classes was assigned a p-value by computing the percentage of permutations in which 627 
the difference between the two connection classes was equal to or exceeded the observed 628 
difference. Standardized effect sizes were approximated using Cohen’s d calculated as the difference 629 
between average cross-disorder involvement of two connection classes divided by the pooled 630 
standard deviation. 631 
 632 
Global white matter  633 
Additional permutation testing was performed to verify independence of our results from 634 
widespread white matter differences in fractional anisotropy. For each subject, global FA was 635 
computed as the total FA strength of all connections. Next, subjects were classified into ten global 636 
FA groups, group one with global FA in the interval [0, 0.1), group two with global FA in the interval 637 
[0.1, 0.2), etc. For permutation testing, subject labels were permuted within datasets, but now 638 
under the constraint of only allowing switching patient and control labels of subjects assigned to the 639 
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same global FA bin. As such, the resulting global FA distribution of permuted patient and control 640 
groups was kept similar to the original global FA distributions (and therewith also potential between-641 
group differences in global FA). 10,000 permutations were computed and, in each permutation, the 642 
cross-disorder involvement of the subsets of connections was calculated. Observed effects were 643 
assigned a p-value as the percentage of the permutations in which the measured effect was equal to 644 
or exceeded the observed effect. 645 
Data availability 646 
The reference connectome dataset was based on data from the Human Connectome Project which 647 
is available from https://www.humanconnectome.org 648 
Datasets ASD II, ASD III and ASD IV were obtained from the ABIDE-II database and are available from 649 
http://fcon_1000.projects.nitrc.org/indi/abide/abide_II.html 650 
Datasets Alzheimer's disease II, MCI II and PTSD II were obtained from the ADNI and DOD-ADNI 651 
database and are available from http://adni.loni.usc.edu 652 
Dataset Schizophrenia III was obtained from the COBRE database and is available from 653 
http://fcon_1000.projects.nitrc.org/indi/retro/cobre.html 654 
Datasets ADHD I, ALS, Alzheimer's disease I, ASD I, Bipolar disorder, MCI I, MDD, Obesity, OCD, PLS, 655 
PTSD I, Schizophrenia I and Schizophrenia II are subject to specific data-sharing restrictions. To 656 
inquire about access to the restricted datasets, please get in touch with the corresponding author.  657 
 658 
Code availability 659 
All code is available from the corresponding author upon reasonable request. 660 
 661 
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Figure 1. Cross-disorder involvement. (a) Overview of data aggregation and analysis. Per disorder, a 922 
connection-wise disorder-specific disconnectivity map was computed contrasting the fractional 923 
anisotropy of connections in patients and matched controls. Disorder-specific disconnectivity maps 924 
were combined to determine the disconnectivity distribution across disorders. (b) Schematic 925 
representation of the human reference connectome with connections colored by cross-disorder 926 
involvement. (c) Superior (left panel), frontal (right-top panel) and medial (right-bottom panel) view 927 
of brain connectivity colored by cross-disorder involvement. (d) Lateral and medial view of left and 928 
right hemispheres showing region-wise cross-disorder involvement. (e) Network including 80 regions 929 
(colored blue) that showed significant involvement across disorders (NBS analysis, p < 0.001, one-930 
sided permutation testing, 10,000 permutations). 931 
 932 
Figure 2. Edge-wise network measures. From left to right, average cross-disorder involvement of 933 
connections with highest edge betweenness centrality (top 25%, n = 290, shown), contributing most 934 
to communicability, contributing most to clustering and long-distance connections. Observed values 935 
(blue) were compared with average cross-disorder involvement of central connections in subject-936 
label permuted cross-disorder involvement maps (grey). Connections important for global 937 
topological (edge betweenness centrality: d = 0.41, one-sided permutation testing, 10,000 938 
permutations, p < 0.001; and communicability: d = 0.18, p = 0.009) and spatial (long-distance 939 
connections, d = 0.62, p < 0.001) integration showed significantly higher cross-disorder involvement 940 
levels than expected for randomly distributed disease effects (indicated by an asterisk *, p < 0.05). 941 
Connections important for local clustering did not show higher than expected cross-disorder 942 
involvement (p = 0.911). Boxes indicate the interval between 25th and 75th percentiles (q1 and q3), 943 
whiskers indicate the interval between q1−1.5×(q3−q1) and q3+1.5×(q3−q1), white lines indicate 944 
median values and white circles indicate mean values. 945 
 946 
Figure 3. Rich club organization. (a) Cross-disorder involvement of rich club connections (n = 88) was 947 
significantly higher as compared to the set of local connections (n = 751, d = 0.43, p < 0.001, one-948 
sided permutation testing, 10,000 permutations) and higher than observed in the set of feeder 949 
connections (n = 321, d = 0.28, p = 0.013). Significant differences are indicated by * (p < 0.05) and 950 
boxes indicate the interval between 25th and 75th percentiles (q1 and q3), whiskers indicate the 951 
interval between q1−1.5×(q3−q1) and q3+1.5×(q3−q1), white lines indicate median values and white 952 
circles indicate mean values. (b) Hub regions (top 13% highest degree regions, 29 regions) are 953 
30 
 
colored in red. (c) Schematic representation of the human reference connectome with rich club 954 
connections (colored red), feeder connections (orange) and local connections (yellow).  955 
 956 
Figure 4. Cross-disorder hyperconnectivity. (a) Lateral and medial view of left and right hemispheres 957 
showing region-wise cross-disorder hyperconnectivity. (b) Schematic representation of the human 958 
reference connectome with connections colored by cross-disorder hyperconnectivity. (c) Average 959 
cross-disorder hyperconnectivity of peripheral connections (blue) was compared with average cross-960 
disorder hyperconnectivity in subject-label permuted cross-disorder involvement maps (grey). 961 
Peripheral connections, with low edge betweenness (n = 290, d = 0.20, p = 0.002, one-sided 962 
permutation testing, 10,000 permutations), small contribution to communicability (d = 0.33, p < 963 
0.001) or short-distance connections (d = 0.27, p < 0.001) showed significantly higher cross-disorder 964 
hyperconnectivity as compared to effects in subject-label permuted null-models. Connections with 965 
low clustering did not show higher than expected cross-disorder hyperconnectivity (p = 0.132). (d) 966 
Cross-disorder hyperconnectivity of rich club, feeder and local connections. Local connections (n = 967 
751) showed higher cross-disorder hyperconnectivity than feeder (n = 321, d = 0.19, p = 0.003, one-968 
sided permutation testing, 10,000 permutations) or rich club connections (n = 88, d = 0.29, p = 969 
0.004). (e) NBS analysis revealed two subnetworks with high cross-disorder involvement (NBS 970 
threshold 30%: p = 0.026; NBS threshold 40%: p = 0.032, one-sided permutation testing, 10,000 971 
permutations). Brain regions (in blue) and schematic representation of the largest significant 972 
subnetwork (NBS threshold > 30%) are presented. Significant differences are indicated by * (p < 973 
0.05) and boxes indicate the interval between 25th and 75th percentiles (q1 and q3), whiskers indicate 974 
the interval between q1−1.5×(q3−q1) and q3+1.5×(q3−q1), white lines indicate median values and 975 
white circles indicate mean values. 976 
 977 
Figure 5. Overlap disorder disconnectivity with cross-disorder involvement map. For each disorder, 978 
the (weighted) disconnectivity of connections was compared between connections commonly 979 
affected across the 11 other disorders (affected in four or more disorders) and more disorder-980 
specific connections (affected in zero, one or two disorders). Schizophrenia (d = 0.77, p < 0.001, two-981 
sided permutation testing, 10,000 permutations, Bonferroni corrected for multiple testing across 12 982 
disorders), PLS (d = 0.71, p < 0.001), ALS (d = 0.71, p < 0.001), bipolar disorder (d = 0.42, p = 0.001), 983 
obesity (d = 0.33, p = 0.019), Alzheimer’s disease (d = 0.31, p = 0.040) and ASD (d = 0.31, p = 0.035) 984 
showed significantly higher disconnectivity in commonly affected connections. MCI (p = 0.073), 985 





Figure 6. Cross-comparison of cross-disorder gray matter abnormalities and region-wise cross-989 
disorder white matter disconnectivity. (a) The vulnerability of 40 brain regions to white-matter 990 
disconnectivity and gray matter abnormalities are plotted with shaded areas indicating the top 5 991 
regions with highest scores for either cross-disorder measure (y-axis starts at 0.015). (b) The average 992 
peak values of 40 brain regions to gray matter abnormalities are illustrated as provided by Crossley 993 







Table 1. Demographics after data quality control and matching.  999 



















ADHD I 14 33 12.07 (2.48) 11.15 (2.54) 0.27 13/1 (92.9/.7.1) 27/6 (81.8/.18.2) 0.33 49
ALS 45 45 50.99 (19.10) 51.98 
(15.98) 
0.79 37/8 (82.2/.17.8) 33/12 (73.3/.26.7) 0.31 74 
Alzheimer's 
disease I 
20 20 61.65 (7.74) 66.00 (5.62) 0.05 8/12 (40.0/.60.0) 11/9 (55.0/.45.0) 0.34 54,75
Alzheimer's 
disease II 
16 36 72.24 (4.54) 75.14 (8.90) 0.23 6/10 (37.5/.62.5) 21/15 (58.3/.41.7) 0.17 ADNI
ASD I 16 32 12.62 (1.86) 12.10 (2.48) 0.47 14/2 (87.5/.12.5) 27/5 (84.4/.15.6) 0.77 49
ASD II 22 32 13.37 (2.99) 12.97 (3.25) 0.65 20/2 (90.9/.9.1) 25/7 (78.1/.21.9) 0.22 ABIDE-II
ASD III 14 13 16.34 (3.31) 14.44 (3.52) 0.18 14/0 (100.0/.0.0) 13/0 (100.0/.0.0) 1.00 ABIDE-II 
ASD IV 28 28 39.36 (15.04) 38.04 
(15.78) 
0.75 28/0 (100.0/.0.0) 28/0 (100.0/.0.0) 1.00 ABIDE-II
Bipolar disorder 82 82 45.18 (14.62) 45.86 
(13.41) 
0.76 42/40 (51.2/.48.8) 49/33 (59.8/.40.2) 0.27 48
MCI I 28 28 57.89 (12.22) 62.79 (7.81) 0.09 15/13 (53.6/.46.4) 19/9 (67.9/.32.1) 0.27 54,75
MCI II 17 95 72.80 (6.74) 72.48 (7.22) 0.87 8/9 (47.1/.52.9) 59/36 (62.1/.37.9) 0.24 ADNI
MDD 476 211 37.20 (11.78) 36.93 
(12.15) 
0.78 209/267 (43.9/.56.1) 104/107 (49.3/.50.7) 0.19 50 
Obesity 32 29 23.53 (8.66) 26.45 
(10.73) 
0.25 15/17 (46.9/.53.1) 10/19 (34.5/.65.5) 0.33 51 
OCD 42 36 31.81 (8.19) 31.50 (9.40) 0.88 18/24 (42.9/.57.1) 14/22 (38.9/.61.1) 0.72 52
PLS 32 32 59.18 (14.60) 59.93 (9.70) 0.81 19/13 (59.4/.40.6) 17/15 (53.1/.46.9) 0.61 74 
PTSD I 25 46 36.92 (10.61) 37.66 (9.46) 0.77 25/0 (100.0/.0.0) 46/0 (100.0/.0.0) 1.00 53
PTSD II 40 40 69.86 (4.50) 68.04 (3.86) 0.06 40/0 (100.0/.0.0) 40/0 (100.0/.0.0) 1.00 DOD 
ADNI 
Schizophrenia I 106 106 29.52 (7.63) 29.44 (7.41) 0.94 71/35 (67.0/.33.0) 82/24 (77.4/.22.6) 0.09 47
Schizophrenia II 24 24 31.79 (7.50) 31.21 (3.55) 0.74 17/7 (70.8/.29.2) 19/5 (79.2/.20.8) 0.50 46 
Schizophrenia III 75 65 37.73 (11.97) 38.43 
(13.47) 
0.75 57/18 (76.0/.24.0) 51/14 (78.5/.21.5) 0.73 COBRE
 1000 
a Independent-samples two-tailed t-test. 1001 
b Two-sided chi-squared test. 1002 
e NBS analysis networkd Region-wise cross-disorder involvement
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